NCT02064738已完成不适用
A Pilot Study of the Effectiveness of a High Omega-3/Low Omega-6 Treatment Diet for Treating Aspirin-exacerbated Respiratory Disease
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- Change in urinary leukotriene E4 levels
研究概览
简要总结
The purpose of this trial is to test the hypothesis that a treatment diet low in omega-6 fatty acids and high in omega-3 fatty acids can cause improvement in asthma symptoms, nasal symptoms, and pulmonary function in patients with aspirin-exacerbated respiratory disease (AERD).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •History of physician-diagnosed asthma
- •History of nasal polyposis
- •History of at least two reactions to oral aspirin or other nonselective cyclooxygenase inhibitor with features of lower airway involvement (cough, chest tightness, wheezing, dyspnea), or diagnosis of AERD via a physician-conducted challenge to aspirin
- •Age between 18 and 70 years
排除标准
- •Current smoking, defined as daily tobacco smoking in the last 6 months and at least one instance of tobacco smoking in the last 3 months.
- •Current pregnancy or breastfeeding
- •History of allergy to fish or any unwillingness to eat fish as a regular part of the diet
- •Use of Zyflo (zileuton) in the last two weeks
- •Presence of an implantable cardioverter-defibrillator
- •Use of oral steroids in the last two weeks
- •Participation in any other clinical trial in the last month
- •Any use of nonsteroidal antiinflammatory drugs (NSAIDs) or any drug that inhibits the cyclooxygenase enzyme during the course of the study
结局指标
主要结局
Change in urinary leukotriene E4 levels
时间窗: 2 weeks and 4 weeks
Change in serum leukotriene B4 levels
时间窗: 2 weeks and 4 weeks
次要结局
- Change in Sino-Nasal Outcome Test-22 (SNOT-22) score(Baseline, 2 weeks, and 4 weeks)
- Change in asthma control questionnaire score(Baseline, 2 weeks, and 4 weeks)
- Change in forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC(Baseline, two weeks, and four weeks)
研究者
Tanya Laidlaw, MD
Assistant Professor of Medicine, Harvard Medical School
Brigham and Women's Hospital
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk WomenBreast CancerNCT02101970Carol Fabian, MD46
已完成
2 期
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive PeriodontitisResidual DiseaseAggressive PeriodontitisNCT03093207Universidade Estadual Paulista Júlio de Mesquita Filho34
已完成
2 期
Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive PeriodontitisAggressive PeriodontitisNCT03093246Universidade Estadual Paulista Júlio de Mesquita Filho38
已完成
1 期
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic PatientsDiabetes, AutoimmuneDiabetes MellitusHypoglycemiaDiabetes Mellitus, Type 1NCT03406897Rodolfo Alejandro27
已完成
不适用
Effect of Omega-3 Fatty Acids on Sleep and Behavior (Pilot Study)Disturbances in Initiating and Maintaining SleepBehavior ProblemNCT03694314University of Pennsylvania29